Establishment Labs guides 2025 revenue $205M-$210M, positive adjusted EBITDA in 2025

ESTABLISHMENT LABS HOLDINGS INC.

2025 revenue guidance of $205M-$210M ($170M-$175M international, $35M US).
Expects positive adjusted EBITDA in 2025.
Expects positive cash flow in 2026.
Guidance provided at J.P. Morgan Healthcare Conference on Jan 15, 2025.

item 7.01

ESTABLISHMENT LABS HOLDINGS INC. filing history →

Source: SEC EDGAR

accession 0001688757-25-000008

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.